About GeneSys Biologics
GeneSys Biologics is a company based in Hyderabad (India) founded in 2014.. GeneSys Biologics has raised $16.7 million across 2 funding rounds from investors including Relentlessbiosciences, P Shanthi and P Chandana. The company has 242 employees as of March 31, 2023. GeneSys Biologics offers products and services including Insulin Biosimilars.
- Headquarter Hyderabad, India
- Employees 242 as on 31 Mar, 2023
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$28.26 K (USD)99as on Mar 31, 2019
-
Net Profit
$-1.41 K (USD)-60as on Mar 31, 2019
-
EBITDA
$28.26 K (USD)99as on Mar 31, 2019
-
Total Equity Funding
$16.7 M (USD)
in 2 rounds
-
Latest Funding Round
$16.25 M (USD), Seed
Oct 11, 2021
-
Investors
Relentlessbiosciences
& 11 more
-
Employee Count
242
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GeneSys Biologics
GeneSys Biologics offers a comprehensive portfolio of products and services, including Insulin Biosimilars. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops affordable alternatives to insulin for diabetes management and treatment
Unlock access to complete
Funding Insights of GeneSys Biologics
GeneSys Biologics has successfully raised a total of $16.7M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $16.25 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $16.2M
-
First Round
First Round
(26 Feb 2020)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2021 | Amount | Seed - GeneSys Biologics | Valuation | Relentlessbiosciences | |
| Feb, 2020 | Amount | Angel Round - GeneSys Biologics | Valuation | Ashwin Balakrishna Athri |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GeneSys Biologics
GeneSys Biologics has secured backing from 12 investors, including institutional and angel investors. Prominent investors backing the company include Relentlessbiosciences, P Shanthi and P Chandana. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
PS
P Shanthi |
-
|
Founded Year | Domain | Location |
|
PC
P Chandana |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GeneSys Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GeneSys Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genesys Biologics Comparisons
Competitors of GeneSys Biologics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about GeneSys Biologics
When was GeneSys Biologics founded?
GeneSys Biologics was founded in 2014 and raised its 1st funding round 6 years after it was founded.
Where is GeneSys Biologics located?
GeneSys Biologics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Is GeneSys Biologics a funded company?
GeneSys Biologics is a funded company, having raised a total of $16.7M across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $459.9K, raised on Feb 26, 2020.
How many employees does GeneSys Biologics have?
As of Mar 31, 2023, the latest employee count at GeneSys Biologics is 242.
What is the annual revenue of GeneSys Biologics?
Annual revenue of GeneSys Biologics is $28.26K as on Mar 31, 2019.
What does GeneSys Biologics do?
GeneSys Biologics was established in 2014 in Hyderabad, India, as an RD entity in the biologics sector. Focus is placed on the development and manufacturing of insulin biosimilars targeting various therapeutic areas. Operations encompass research processes, production protocols, and quality controls to support pharmaceutical needs. The companys activities are centered in India, with an online presence at genesysbiologics.com, serving global biosimilar demands.
What products or services does GeneSys Biologics offer?
GeneSys Biologics offers Insulin Biosimilars.
Who are GeneSys Biologics's investors?
GeneSys Biologics has 12 investors. Key investors include Relentlessbiosciences, P Shanthi, P Chandana, Smitha Yalamanchili, and Gayathri Joganpally.
What is GeneSys Biologics's valuation?
The valuation of GeneSys Biologics is $54.13M as of Oct 2021.